Stocktoria
Addus HomeCare Corp ADUS
Addus HomeCare Corp (ADUS) earns a Piotroski F-score of 7/9 (strong financial health), with an Altman Z″ in the safe zone. It does not currently pay a dividend. FY2025 revenue was $1.4B at a 6.7% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.26 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 7/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.083 |
| Retained earnings / assets | 0.329 |
| EBIT / assets | 0.096 |
| Equity / liabilities | 3.083 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| ADUS | Addus HomeCare Corp | 7/9 | 5.5 | 18.9 | +23.2% |
| AVAH | Aveanna Healthcare Holdings, Inc. | 6/9 | -0.46 | 8.4 | +20.2% |
| CHE | CHEMED CORP | 5/9 | 9.65 | 23.2 | +4.1% |
| EDGM | Edgemode, Inc. | 3/9 | — | — | — |
| AHCO | AdaptHealth Corp. | 5/9 | 0.26 | — | -0.5% |
| OPCH | Option Care Health, Inc. | 5/9 | 2.97 | 16.5 | +13% |
| BTSG | BrightSpring Health Services, Inc. | 7/9 | 1.78 | 71 | +28.2% |
About Addus HomeCare Corp
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. Its Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. Its Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company serves federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.
FAQ
Is ADUS financially healthy?
Addus HomeCare Corp's Piotroski F-score is 7/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does ADUS pay a dividend?
No, Addus HomeCare Corp does not currently pay a dividend.
How profitable is ADUS?
In FY2025, Addus HomeCare Corp had a net margin of 6.7% and a return on equity of 8.8%.
Is ADUS overvalued or undervalued?
Addus HomeCare Corp trades at about 22.6× trailing earnings — below its 10-year norm (10-year range 19.8×–54.1×, median 34.8×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for ADUS?
The average Wall-Street price target for Addus HomeCare Corp is $132.69, about 12.4% above the recent price, from 13 analysts (consensus: buy).
Is ADUS a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Addus HomeCare Corp: a Piotroski F-score of 7/9, an Altman Z″ in the safe zone, a P/E of about 18.9×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.